Paloma Partners Management CO Glaukos Corp Transaction History

Paloma Partners Management CO

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$47.43 - $84.23 $194,463 - $345,343	-4,100 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$73.06 - $97.7 $527,347 - $705,198	-7,218 Reduced 63.77%	4,100 $348,000
Q1 2021 May 17, 2021	BUY	$70.43 - $97.42 $581,188 - $803,909	8,252 Added 269.15%	11,318 $950,000
Q4 2020 Feb 16, 2021	BUY	$48.9 - $75.26 $149,927 - $230,747	3,066 New	3,066 $231,000
Q2 2020 Aug 14, 2020	SELL	$28.78 - $46.83 $290,937 - $473,404	-10,109 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$25.53 - $70.14 $23,079 - $63,406	-904 Reduced 8.21%	10,109 $312,000
Q4 2019 Feb 14, 2020	SELL	$54.18 - $65.64 $149,699 - $181,363	-2,763 Reduced 20.06%	11,013 $600,000
Q3 2019 Nov 14, 2019	BUY	$58.58 - $83.91 $806,998 - $1.16 Million	13,776 New	13,776 $861,000
Q2 2019 Aug 14, 2019	SELL	$63.59 - $78.71 $212,962 - $263,599	-3,349 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$50.75 - $80.54 $169,961 - $269,728	3,349 New	3,349 $262,000

345

46.7M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $7.63B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

Stay updated on Paloma Partners Management CO with notifications on news.